Bankruptcy Court for the Southern District of New York. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. The company’s International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women’s health, oncology, and transplantation. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company’s Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection ADRENALIN, a non-selective adrenergic agonist and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren’s contracture SUPPRELIN LA to treat central precocious puberty in children NASCOBAL nasal spray to treat vitamin B12 deficiency AVEED to treat hypogonadism QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women PERCOCET to treat moderate-to-moderately-severe pain TESTOPEL, an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone EDEX to treat erectile dysfunction LIDODERM a topical patch product containing lidocaine for the relief of pain and products for the pain management and urology. Healey’s office said that formula “did nothing to deter oral abuse and led to deadly outbreaks of Hepatitis and HIV due to its widespread abuse via injection.Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. It’s not yet clear exactly how much of the total pot Massachusetts will receive.Īttorneys general alleged that Endo falsely promoted Opana ER, which was withdrawn from the market in 2017, by touting its abuse-deterrent formula. ET You’re reading a free article with opinions that may differ from. “The money recovered from this settlement will help to fund treatment, harm reduction and prevention throughout the country, and the ban on promotion and document disclosure requirements will ensure this never happens again.” Endo International Market Cap 2M Today's Change (-20.00) -0.00 Current Price 0.01 Price as of July 12, 2023, 3:26 p.m. “Endo’s deceptive marketing fueled the opioid crisis and caused a massive human toll,” Healey said in a statement. It would also prohibit the marketing of Endo’s opioids forever. The deal would require the manufacturer of Percocet, Endocet and other generic and branded opioids to pay $450 million over a 10-year period to participating states and subdivisions, submit opioid-related documents for online publication and pay $2.75 million to cover archival expenses, according to Healey’s office. Healey said she and her peers in other states reached an agreement in principle with Endo International plc to resolve allegations that the company used deceptive marketing techniques and downplayed the risks of addiction to boost its sales. Part of a $450 million payment from opioid manufacturer Endo, which filed for bankruptcy Tuesday night, is being wired to the Bay State under a deal Attorney General Maura Healey and several other state AGs struck with the company.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |